tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Fisher & Paykel Healthcare Corrects Director Shareholding Disclosure

Story Highlights
  • Fisher & Paykel Healthcare corrected a prior disclosure, confirming executive Justin Callahan now holds 220,738 ordinary shares.
  • The updated filing reflects his purchase of 145 shares via the Employee Stock Purchase Plan, slightly increasing insider ownership accuracy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Fisher & Paykel Healthcare Corrects Director Shareholding Disclosure

Claim 50% Off TipRanks Premium

Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ) has shared an update.

Fisher & Paykel Healthcare has corrected an error in an ongoing disclosure notice filed earlier this month, clarifying that Vice President of Sales & Marketing Justin Peter Callahan holds 220,738 ordinary shares in the company following a recent acquisition, rather than the 200,738 previously stated. The revision reflects his purchase of 145 ordinary shares at NZD 32.1985 each through the company’s Employee Stock Purchase Plan, a routine transaction that slightly increases insider ownership and ensures the market has accurate information on senior management’s equity interests.

More about Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical technology company that designs, manufactures and markets respiratory care and acute care products for hospitals and homecare, with a focus on humidification therapies and related equipment used globally in respiratory support and sleep apnea treatment.

Learn more about FSPKF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1